  Background: Many studies have been conducted on the genetic and epigenetic
etiology of gestational diabetes mellitus (GDM) in the last two decades because
of the diseases increasing prevalence and role in the global diabetes mellitus
(DM) explosion. An update on the genetic and epigenetic etiology of GDM then
becomes imperative to better understand and stem the rising incidence of the
disease. This review, therefore, articulated GDM candidate genes and their
pathophysiology for the awareness of stakeholders. Main body (genetic and
epigenetic etiology, GDM): The search discovered 83 GDM candidate genes, of
which TCF7L2, MTNR1B, CDKAL1, IRS1, and KCNQ1 are the most prevalent. Certain
polymorphisms of these genes can modulate beta-cell dysfunction, adiposity,
obesity, and insulin resistance through several mechanisms. Environmental
triggers such as diets, pollutants, and microbes may also cause epigenetic
changes in these genes, resulting in a loss of insulin-boosting and glucose
metabolism functions. Early detection and adequate management may resolve the
condition after delivery; otherwise, it will progress to maternal type 2
diabetes mellitus (T2DM) and fetal configuration to future obesity and DM. This
shows that GDM is a strong risk factor for T2DM and, in rare cases, type 1
diabetes mellitus (T1DM) and maturity-onset diabetes of the young (MODY). This
further shows that GDM significantly contributes to the rising incidence and
burden of DM worldwide and its prevention may reverse the trend. Conclusion:
Mutations and epigenetic changes in certain genes are strong risk factors for
GDM. For affected individuals with such etiologies, medical practitioners
should formulate drugs and treatment procedures that target these genes and
their pathophysiology.
